# BriaCell Therapeutics Corp.: Form 40-F for the period ended Jul 31, 2021

- Company: [BriaCell Therapeutics Corp.](/companies/bctx.md) (CIK 1610820)
- Form: 40-F
- Filed: 2021-10-29
- Accepted by EDGAR: Oct 29, 2021, 16:15 ET
- Period: 2021-07-31
- Accession: 0001493152-21-026729
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1610820/000149315221026729/form40-f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1610820/000149315221026729/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1610820/000149315221026729/form40-f.htm

Filed Oct 29, 2021.
Source: SEC EDGAR, the filing index for accession 0001493152-21-026729. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.
